Association of IGF-1 with coronary collateral circulation in stable coronary artery disease

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 Berry C, Balachandran KP, L'Allier PL, Lespérance J, Bonan R, Oldroyd KG. Importance of collateral circulation in coronary heart disease. Eur. Heart J. 28(3), 278–291 (2007).
  MedlineGoogle Scholar
• 2 Kersten JR, Pagel PS, Chilian WM, Warltier DC. Multifactorial basis for coronary collateralization: a complex adaptive response to ischemia. Cardiovasc. Res. 43(1), 44–57 (1999).
  Medline CASGoogle Scholar
• 3 Ferns G, Motani A, Anggård E. The insulin-like growth factors: their putative role in atherogenesis. Artery 18(4), 197–225 (1990).
  Google Scholar
• 4 Bang P, Eriksson U, Sara V, Wivall IL, Hall K. Comparison of acid ethanol extraction and acid gel filtration prior to IGF-I and IGF-II radioimmunoassays: improvement of determinations in acid ethanol extracts by the use of truncated IGF-I as radioligand. Acta Endocrinol. 124(6), 620–629 (1991).
  Medline CASGoogle Scholar
• 5 Ranke M, Kietzmann K. A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin-binding protein: its use for diagnosis of GH deficiency. J. Clin. Endocrinol. Metab. 70(5), 1292–1299 (1990).
  MedlineGoogle Scholar
• 6 Juul A, Dalgaard P, Blum WF et al. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. J. Clin. Endocrinol. Metab. 80(8), 2534–2542 (1995).
  Medline CASGoogle Scholar
• 7 Nyström FH, Öhman PK, Ekman BÅ, Österlund MK, Karlberg BE, Arnqvist HJ. Population-based reference values for IGF-I and IGF-binding protein-1: relations with metabolic and anthropometric variables. Eur. J. Endocrinol. 136(2), 165–172 (1997).
  Medline CASGoogle Scholar
• 8 Juul A, Scheike T, Davidsen M, Gyllenborg J, Jørgensen T. Low serum insulin-like growth factor i is associated with increased risk of ischemic heart disease a population-based case-control study. Circulation 106(8), 939–944 (2002).
  Medline CASGoogle Scholar
• 9 Higashi Y, Sukhanov S, Anwar A, Shai SY, Delafontaine P. Aging, atherosclerosis, and IGF-1. J. Gerontol. A Biol. Sci. Med. Sci. 67(6), 626–639 (2012).
  MedlineGoogle Scholar
• 10 Sukhanov S, Higashi Y, Shai SY et al. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases Atherosclerosis progression in ApoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 27(12), 2684–2690 (2007). •• Impacts on importance of IGF-1 in inflammation, oxidative stress and atherosclerosis.
  Medline CASGoogle Scholar
• 11 Rentrop KP, Cohen M, Blanke H, Phillips RA. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J. Am. Coll. Cardiol. 5(3), 587–592 (1985).
  Medline CASGoogle Scholar
• 12 Habib G, Heibig J, Forman S et al. Influence of coronary collateral vessels on myocardial infarct size in humans. Results of Phase I thrombolysis in myocardial infarction (TIMI) trial. The TIMI Investigators. Circulation 83(3), 739–746 (1991).
  Medline CASGoogle Scholar
• 13 Smith RD, Ilsley CD. Clinical contribution of the collateral circulation to myocardial protection. Coron. Artery Dis. 15(7), 393–398 (2004).
  MedlineGoogle Scholar
• 14 Hansen JF. Coronary collateral circulation: clinical significance and influence on survival in patients with coronary artery occlusion. Am. Heart J. 117(2), 290–295 (1989).
  Medline CASGoogle Scholar
• 15 Billinger M, Kloos P, Eberli FR, Windecker S, Meier B, Seiler C. Physiologically assessed coronary collateral flow and adverse cardiac ischemic events: a follow-up study in 403 patients with coronary artery disease. J. Am. Coll. Cardiol. 40(9), 1545–1550 (2002).
  MedlineGoogle Scholar
• 16 Pohl T, Seiler C, Billinger M et al. Frequency distribution of collateral flow and factors influencing collateral channel development: functional collateral channel measurement in 450 patients with coronary artery disease. J. Am. Coll. Cardiol. 38(7), 1872–1878 (2001).
  Medline CASGoogle Scholar
• 17 Akboga MK, Akyel A, Sahinarslan A et al. Relationship between plasma apelin level and coronary collateral circulation. Atherosclerosis 235(2), 289–294 (2014).
  Medline CASGoogle Scholar
• 18 Sun Z, Shen Y, Lu L et al. Clinical and angiographic features associated with coronary collateralization in stable angina patients with chronic total occlusion. J. Zhejiang Univ. Sci. B 14(8), 705–712 (2013).
  MedlineGoogle Scholar
• 19 Kornowski R. Collateral formation and clinical variables in obstructive coronary artery disease: the influence of hypercholesterolemia and diabetes mellitus. Coron. Artery Dis. 14(1), 61–64 (2003).
  MedlineGoogle Scholar
• 20 Nagai Y, Tasaki H, Miyamoto M et al. Plasma level of homocysteine is inversely-associated with the development of collateral circulation in patients with single-vessel coronary artery disease. Circ. J. 66(2), 158–162 (2002).
  Medline CASGoogle Scholar
• 21 Fujita M, Tambara K. Recent insights into human coronary collateral development. Heart 90(3), 246–250 (2004).
  Medline CASGoogle Scholar
• 22 Lee CW, Stabile E, Kinnaird T et al. Temporal patterns of gene expression after acute hindlimb ischemia in mice: insights into the genomic program for collateral vessel development. J. Am. Coll. Cardiol. 43(3), 474–482 (2004).
  Medline CASGoogle Scholar
• 23 Glasser SP, Selwyn AP, Ganz P. Atherosclerosis: risk factors and the vascular endothelium. Am. Heart J. 131(2), 379–384 (1996).
  Medline CASGoogle Scholar
• 24 Schaper W, Sharma HS, Quinkler W, Markert T, Wonsch M, Schaper J. Molecular biologic concepts of coronary anastomoses. J. Am. Coll. Cardiol. 15(3), 513–518 (1990).
  Medline CASGoogle Scholar
• 25 Gryglewski R, Palmer R, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 320(6061), 454–456 (1986).
  Medline CASGoogle Scholar
• 26 Diaz MN, Frei B, Vita JA, Keaney JF Jr. Antioxidants and atherosclerotic heart disease. N. Engl. J. Med. 337(6), 408–416 (1997).
  Medline CASGoogle Scholar
• 27 Cebi A, Kaya Y, Gungor H et al. Trace elements, heavy metals and vitamin levels in patients with coronary artery disease. Int. J. Med. Sci. 8(6), 456–460 (2011).
  Medline CASGoogle Scholar
• 28 Hattan N, Chilian WM, Park F, Rocic P. Restoration of coronary collateral growth in the Zucker obese rat. Basic Res. Cardiol. 102(3), 217–223 (2007).
  Medline CASGoogle Scholar
• 29 Yousefzadeh G, Masoomi M, Emadzadeh A, Shahesmaeili A, Sheikhvatan M. The association of insulin-like growth factor-1 with severity of coronary artery disease. J. Cardiovasc. Med. 14(6), 416–420 (2013). • First study to show the relationship between IGF-1 and severity of coronary artery disease as assessed with Gensini score.
  CASGoogle Scholar
• 30 Burchardt P, Gozdzicka-Jozefiak A, Zurawski J et al. Are elevated levels of igf-1 caused by coronary arteriesoclerosis?: molecular and clinical analysis. Protein J. 29(8), 538–544 (2010).
  Medline CASGoogle Scholar
• 31 Kajantie E, Fall CH, Seppala M et al. Serum insulin-like growth factor (igf)-i and igf-binding protein-1 in elderly people: Relationships with cardiovascular risk factors, body composition, size at birth, and childhood growth. J. Clin. Endocrinol. Metab. 88(3), 1059–1065 (2003).
  Medline CASGoogle Scholar
• 32 Després J-P, Lemieux I, Prud'Homme D. Treatment of obesity: need to focus on high risk abdominally obese patients. Br. Med. J. 322(7288), 716–720 (2001).
  Medline CASGoogle Scholar
• 33 Spallarossa P, Brunelli C, Minuto F et al. Insulin-like growth factor-1 and angiographically documented coronary artery disease. Am. J. Cardiol. 77(2), 200–202 (1996).
  Medline CASGoogle Scholar
• 34 Janssen J, Stolk R, Pols H, Grobbee D, Lamberts S. Serum total IGF-I, free IGF-I, and IGFBP-1 levels in an elderly population. Arterioscler. Thromb. Vasc. Biol. 18(2), 277–282 (1998).
  Medline CASGoogle Scholar
• 35 Carlzon D, Svensson J, Petzold M et al. Both low and high serum IGF-1 levels associate with increased risk of cardiovascular events in elderly men. J. Clin. Endocrinol. Metab. 99(11), 2308–2316 (2014).
  Google Scholar
• 36 Koenig W, Sund M, Fröhlich M et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 99(2), 237–242 (1999).
  Medline CASGoogle Scholar
• 37 Fichtlscherer S, Rosenberger G, Walter DH, Breuer S, Dimmeler S, Zeiher AM. Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation 102(9), 1000–1006 (2000).
  Medline CASGoogle Scholar
• 38 Teragawa H, Fukuda Y, Matsuda K et al. Relation between C reactive protein concentrations and coronary microvascular endothelial function. Heart 90(7), 750–754 (2004).
  Medline CASGoogle Scholar
• 39 Amano K, Matsubara H, Iba O et al. Enhancement of ischemia-induced angiogenesis by eNOS overexpression. Hypertension 41(1), 156–162 (2003).
  Medline CASGoogle Scholar
• 40 Matsunaga T, Warltier DC, Weihrauch DW, Moniz M, Tessmer J, Chilian WM. Ischemia-induced coronary collateral growth is dependent on vascular endothelial growth factor and nitric oxide. Circulation 102(25), 3098–3103 (2000).
  Medline CASGoogle Scholar
• 41 Zorkun C, Akkaya E, Zorlu A, Tandogan I. Determinants of coronary collateral circulation in patients with coronary artery disease. Anatol. J. Cardiol. 13(2), 146–151 (2013).
  CASGoogle Scholar
• 42 Gulec S, Ozdemir A, Maradit-Kremers H, Dincer I, Atmaca Y, Erol C. Elevated levels of C-reactive protein are associated with impaired coronary collateral development. Eur. J. Clin. Invest. 36(6), 369–375 (2006). •• Impacts on importance of inflammation in coronary collateral circulation.
  Medline CASGoogle Scholar